Ureteropelvic Junction Obstruction, Ureteropelvic Junction; Obstruction, Congenital
Conditions
Keywords
shared decision making, pragmatic trial, congenital kidney anomaly
Brief summary
Ureteropelvic junction obstruction (UPJO) is the most common etiology of high-grade hydronephrosis, affecting approximately 4,000-10,000 infants annually in the U.S. The goal of surgical treatment of UPJO is to minimize the risk of kidney damage associated with obstruction, which may occur in 30-60% of infants with high-grade hydronephrosis.1-However, the benefit of early surgery compared to observation and potential later surgery to preserve kidney function has not been well-defined. Consequently, surgeons differ on whether to initially treat with surgery or observation, with surgical rates in the first year of life varying from 15-50% across surgical practices. These variations are important to understand, as the decision for early surgery is not without risk. Prior studies suggest that infants treated surgically are at higher risk for readmission and reoperation. Early surgery also raises concerns about neurodevelopmental effects of anesthetic exposure. To address this gap, the purpose of this pilot test is to develop a patient decision aid (PtDA) tool and pilot test its effect on parental understanding and engagement in the decision-making process at Children's Hospital Colorado. The proposed pilot is a necessary first step in preparation for a future multicenter hybrid effectiveness-implementation trial. This work will also be used to support future studies evaluating the impact of a PtDA on surgical variations and treatment outcomes in patients with UPJO and other complex congenital urologic anomalies.
Interventions
BEHAVIORALParent Decision Aid
A paper parent decision aid in color will be provided to all patients at the time of their appointment and will aid in discussion with health care professionals.
Sponsors
Children's Hospital Colorado
University of Colorado, Denver
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to 89 Years
Healthy volunteers
No
Inclusion criteria
(all of following are needed): * parents (age 18-89 years) of children age 30 days - 2 years * child is presenting for consultation for SFU grade 3-4 Hydronephrosis at Children's Hospital Colorado * parents/child presenting at Urology appointment where a MAG 3 is performed or has recently been performed.
Exclusion criteria
* does not meet age parameters * does not have a child with a UPJO
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Differences in the SDM-Q9 scores between arms | through study completion, an average of 1 year | The primary outcome will be differences in scores between the 9-item Shared Decision Making Questionnaire (SDM-Q9) survey scores between intervention and control arms. The SDM-Q9 is a validated survey instrument measuring patient understanding and engagement in the decision making process. The scale for each question is 1-5 and higher scores mean better parent involvment and understanding. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Assess differences in treatment decisions | through study completion, an average of 1 year | The surgical rates of each patient will be assessed in each arm. Demographic variables will be controlled for especially race, ethnicity, socioeconomic variables. |
Countries
United States
Contacts
Primary ContactAlison Saville, MSPH, MSW
Outcome results
None listed